Charles Morris

Charles Morris

Directeur Technique/Scientifique/R&D chez PRELUDE THERAPEUTICS INCORPORATED
61 ans
Health Technology
Consumer Services

Profil

Charles Q.
Morris
is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Postes actifs de Charles Morris

SociétésPosteDébut
PRELUDE THERAPEUTICS INCORPORATED Directeur Technique/Scientifique/R&D 20/04/2026
Corporate Officer/Principal 09/07/2010

Anciens postes connus de Charles Morris

SociétésPosteFin
LAVA THERAPEUTICS N.V. Directeur Technique/Scientifique/R&D 01/10/2025
CELYAD ONCOLOGY SA Directeur Technique/Scientifique/R&D 01/01/2023
RADIUS HEALTH, INC. Directeur Technique/Scientifique/R&D 15/12/2020
Corporate Officer/Principal 01/09/2018
IMMUNOGEN, INC. Corporate Officer/Principal 02/09/2016
Voir l'expérience en détail de Charles Morris

Formation de Charles Morris

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. Charles Morris
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT